Repository logo
 

A third HSAN5 mutation disrupts the nerve growth factor furin cleavage site.

Published version
Peer-reviewed

Type

Article

Change log

Authors

Nahorski, Michael S 
Woods, C Geoffrey 

Abstract

Bi-allelic dysfunctional mutations in nerve growth factor (NGF) cause the rare human phenotype hereditary sensory and autonomic neuropathy type 5 (HSAN5). We describe a novel NGF mutation in an individual with typical HSAN5 findings. The mutation c.361C>T, p.R121W is at the last residue of the furin cleavage motif Arg-Ser-Lys-Arg in proNGF. We show that the p.R121W mutation completely abolishes the formation of mature NGF-β. Surprisingly, mutant p.R121W cells produced very little proNGF. Instead, the two progressive cleavage products of proNGF were produced, proA-NGF and proB-NGF, with proB-NGF being the predominant NGF-derived peptide and the only peptide secreted by mutant p.R121W cells. We found that the ability of the p.R121W mutation to cause tropomyosin receptor kinase A autophosphorylation and mitogen-activated protein kinase phosphorylation was significantly reduced compared to controls (p < 0.05 and p < 0.01). By studying the PC12 cell line morphology and neurite length over a week, we found the p.R121W mutation had residual, but much reduced, neurotrophic activity when compared to wild-type NGF. Finally, we assessed whether the p.R121W mutation affected apoptosis and found a reduced protective effect compared to wild-type NGF. Our results suggest that the p.R121W NGF mutation causes HSAN5 through negating the ability of furin to cleave proNGF to produce NGF-β.

Description

Keywords

HSAN5, Nerve growth factor, furin cleavage, mutation, Animals, Hereditary Sensory and Autonomic Neuropathies, Mutation, Nerve Growth Factor, Neurites, Neurons, PC12 Cells, Phosphorylation, Protein Precursors, Rats

Journal Title

Mol Pain

Conference Name

Journal ISSN

1744-8069
1744-8069

Volume Title

14

Publisher

SAGE Publications
Sponsorship
MRC (MR/K017551/1)
Wellcome Trust (via University College London (UCL)) (532344)
SSS was funded by the UK Medical Research Council (MR/K017551/1), and MSN by the Wellcome Trust (200183/Z/15/Z).